Journal of Applied Physiology Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 100: 465-473, 2006. First published October 13, 2005; doi:10.1152/japplphysiol.01062.2005
8750-7587/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
100/2/465    most recent
01062.2005v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frisbee, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frisbee, J. C.

Impaired hemorrhage tolerance in the obese Zucker rat model of metabolic syndrome

Jefferson C. Frisbee

Department of Physiology and Pharmacology, Center for Interdisciplinary Research in Cardiovascular Sciences, West Virginia University School of Medicine, Morgantown, West Virginia

Submitted 30 August 2005 ; accepted in final form 11 October 2005


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
As obese Zucker rats (OZR) manifesting the metabolic syndrome exhibit enhanced vascular adrenergic constriction and potentially an enhanced adrenergic activity vs. lean Zucker rats (LZR), this study tested the hypothesis that OZR exhibit an improved tolerance to progressive hemorrhage. Preliminary experiments indicated that, corrected for body mass, total blood volume was reduced in OZR vs. LZR. Anesthetized LZR and OZR had a cremaster muscle prepared for in situ videomicroscopy and had renal, splanchnic, hindlimb, and skeletal muscle perfusion monitored with flow probes. Arterial pressure, arteriolar reactivity to norepinephrine, and tissue/organ perfusion were monitored after either infusion of phentolamine or successive withdrawals of 10% total blood volume. Phentolamine infusion indicated that regional adrenergic tone under control conditions differs substantially between LZR and OZR, whereas with hemorrhage OZR exhibit decompensation in arterial pressure before LZR. Renal, distal hindlimb, and skeletal muscle perfusion decreased more rapidly and to a greater extent in OZR vs. LZR after hemorrhage. In contrast, hemorrhage-induced reductions in splanchnic perfusion in OZR lagged behind those in LZR, although a similar maximum reduction was ultimately attained. With increasing hemorrhage, cremasteric arteriolar tone increased more in OZR than LZR, and this increase in active tone was entirely due to an elevated adrenergic contribution. Norepinephrine-induced arteriolar constriction was greater in OZR vs. LZR under control conditions and during hemorrhage, with arterioles from OZR demonstrating early closure vs. LZR. These results suggest that a combination of reduced blood volume and elevated peripheral adrenergic constriction contribute to impaired hemorrhage tolerance in OZR.

microcirculation; blood flow regulation; rodent models of the metabolic syndrome; obesity


AS REPORTED BY THE AMERICAN HEART ASSOCIATION (3, 4) and the Centers for Disease Control (8, 16), ~135 million American adults are classified as overweight with more than 63 million of these individuals classified as obese (body mass index of >30 kg/m2). Although overweight/obesity represents a significant independent risk factor for the development of peripheral vascular disease and alone contributes to the death of an estimated 300,000 American adults annually (4), when combined with other systemic diseases, including insulin resistance, dyslipidemia, and hypertension, this constellation of pathologies leads to the genesis of the metabolic syndrome, a condition impacting ~47 million American adults (3, 16) and that dramatically elevates the risk for the development of cardiovascular disease and mortality (9).

As recently reviewed by van Baak (24), sympathetic neural activity in general tends to be elevated in obese individuals, and microneurographic recordings from the peroneal nerve (innervating the skeletal muscle circulation) demonstrate a strong positive correlation with body mass index and adiposity (18, 19). Furthermore, whole body norepinephrine spillover has also been demonstrated to be positively correlated with adiposity (25). Although these responses have not been universally observed (15), and much of the variability may reflect alterations in diet and physical activity (5), existing data generally demonstrate an increased level of sympathetic nervous system activity with obesity and that this elevated sympathetic nervous system activity may be associated with the development of other elements of the metabolic syndrome, including insulin resistance, dyslipidemia, and hypertension (13, 24).

We and others have previously used the obese Zucker rat model of the metabolic syndrome to investigate alterations in cardiovascular function that evolve under this pathological condition. One consistent element of these studies that has been observed is an elevated adrenergic constrictor reactivity of conduit arteries (23) and in the renal (1, 20) and skeletal muscle microcirculation (10, 11, 21), with the potential to negatively impact normal patterns of perfusion (10, 11). Based on these previous observations, we hypothesized that the adult obese Zucker rat may have an improved tolerance to progressive hemorrhage, a stress for which the immediate compensation is an increased sympathetic neural activity and a constriction of the peripheral circulation (6). The purpose of the present study was to determine whether an increased sympathetic neural activity (7, 17) and an increased reactivity of peripheral microvessels to adrenergic stimuli would contribute to a protection of the obese Zucker rat from entering into decompensation [i.e., a negative slope for the change in mean arterial pressure (MAP) vs. time] following progressive incremental hemorrhage.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Animals.   Male 15- to 17-wk-old lean and obese Zucker rats (LZR and OZR, respectively) were used for all experiments. Rats were housed in an Association for Assessment and Accredation of Laboratory Animals Care-accredited animal care facility, were fed standard chow and tap water ad libitum, and all protocols received prior Institutional Animal Care and Use Committee approval. After an overnight fast, rats were anesthetized with injections of pentobarbital sodium (50 mg/kg ip) and received tracheal intubation to facilitate maintenance of a patent airway. In all rats, a carotid artery and an external jugular vein were cannulated for determination of arterial pressure and for intravenous infusion of supplemental anesthetic, if necessary. While under anesthetic, an aliquot of blood was drawn from the jugular vein to be used for the biochemical determination of plasma glucose and insulin concentrations (Linco Research, St. Charles, MO) as well as a plasma lipid profile (ACE Autoanalyzer, Alfa Wasserman, West Caldwell, NJ) from each animal.

Evaluation of regional adrenergic tone.   To determine the relative degree of adrenergic tone to key organs/tissues and the contribution of this process in regulating blood flow under control conditions, anesthetized rats (n = 5 LZR and n = 5 OZR) had a femoral artery (immediately proximal to the knee) and the contralateral gastrocnemius muscle exposed, and either a renal artery or the superior mesenteric artery isolated (i.e., in no single animal was both the renal and superior mesenteric artery isolated). In addition to chronically measuring MAP, blood flow was measured through the isolated arteries (0.7 PSB; Transonic, Ithaca, NY) or capillary perfusion within the skeletal muscle (OxyFlo, Oxford Optronix; Milton Park, Oxford, UK) under control conditions and following intravenous infusion of 5 mg/kg of the combined {alpha}1/{alpha}2-adrenergic receptor antagonist phentolamine (Sigma; Ref. 22).

Determination of blood volume.   Existing literature indicates that circulating blood volume in rats is ~7% of total body mass (27). However, a recent study by Schreihofer et al. (20) suggests that this value is reduced to between 3 and 4% of total body mass in OZR. As such, after following the above procedures, blood volume in the LZR and OZR was evaluated using a dye dilution technique. Briefly, 1 mg of Evans blue dye (Sigma) was injected intravenously into each rat, as described previously (20, 26). After 10 min, ~1 ml of blood was removed via the carotid cannula. From this aliquot, hematocrit was determined and the remainder was centrifuged to separate the plasma. Plasma (200 µl) was diluted to a 2-ml total volume with saline, and absorbance was determined at 604 nm. The average of two measurements was compared with a standard curve, generated using 10 ml of homologous donor blood of equal hematocrit, as described previously (20, 26). From this value, blood volume was calculated as:

Formula
where BV and PV represent blood and plasma volume (in ml), respectively, and Hct represents blood hematocrit (%).

Evaluation of responses to progressive hemorrhage.   In a separate group of animals, after the initial surgery in the neck, the right cremaster muscle from 20 LZR and 20 OZR was prepared for in situ investigation as described previously (12), with special attention paid to not disrupt the deferential feed vessels (14). Once completed, the cremaster muscle was continuously bathed in warmed (35°C) physiological salt solution while the remainder of the surgical procedure was completed. The ionic composition of the PSS was as follows (in mM): 119.0 NaCl, 4.7 KCl, 1.6 CaCl2, 1.18 NaH2PO4, 1.17 MgSO4, and 24.0 NaHCO3. Subgroups of these rats then received subsequent surgical procedures to isolate the left renal artery (n = 6 LZR and n = 6 OZR) and the left femoral artery immediately proximal to the knee (n = 7 LZR and n = 8 OZR). A microcirculation blood flow probe was placed around the vessels (0.7 and 0.5 PSB, respectively; Transonic) to monitor blood flow during the subsequent hemorrhage procedures. Finally, the left gastrocnemius muscle was exposed, and a laser Doppler flow probe (OxyFlo) was placed against the muscle to monitor skeletal muscle perfusion (n = 4 LZR and n = 5 OZR had gastrocnemius muscle perfusion monitored). At the conclusion of these procedures, rats were placed into a transilluminated videomicrope such that the cremaster muscle microcirculation could be visualized.

In an additional group of rats (n = 5 LZR and n = 6 OZR), the cremaster muscle was surgically prepared as described above but remained covered in PSS-soaked gauze and was not put in place for videomicroscopy. In these animals, the superior mesenteric artery was isolated and a microcirculation blood flow probe was placed around this vessel (0.7 PSB) to monitor blood flow during the subsequent hemorrhage procedures. Finally, the left gastrocnemius muscle was cleared of all overlying tissue, and a laser-Doppler flow probe (OxyFlo) was placed against the muscle to monitor skeletal muscle perfusion (as above, of the 5 LZR and 6 OZR in this grouping, n = 3 LZR and n = 3 OZR had gastrocnemius muscle perfusion monitored). Preliminary experiments demonstrated that the acquisition of a consistent blood flow signal through the superior mesenteric artery could not be reliably performed with the animal and the cremaster muscle in place within the microscope field. After all surgical procedures, each animal received an intravenous infusion of 1,000 IU/kg heparin (Elkins-Sinn, Cherry Hill, NJ), and all exposed surgical areas were covered in PSS-soaked gauze to minimize evaporative water loss.

Progressive hemorrhage protocol.   In each animal, MAP was continuously monitored via the carotid artery cannula, whereas perfusion through the superior mesenteric artery, renal artery, distal femoral artery, or gastroncemius muscle was monitored using the respective flow probe.

After the animal was placed within the videomicroscope and a postsurgical equilibration period of 30 min, a second-order arteriole (~60-µm diameter) was identified in a clearly visible region of the cremaster muscle. This vessel was examined along its length until a suitable bifurcation was identified in which a third-order branch of the vessel would serve as the arteriole of interest. Arterioles chosen for study had walls that were clearly visible, a brisk flow velocity, and active tone, as indicated by the occurrence of significant dilation in response to topical application of 10–3 M adenosine. All arterioles that were studied were located in a region of the muscle that was away from any incision.

Subsequently, individual rats were subjected to a blood loss of ~10% of the total circulating blood volume (taken from the estimation derived above). The blood was withdrawn from the carotid artery cannula and occurred over a 3-min period. Subsequently, each rat was allowed 40 min of recovery time before the second blood withdrawal (an additional ~10% of the original blood volume). This process was repeated until the anesthetized rat either died in response to blood withdrawal or demonstrated a decompensation (a negative slope in blood pressure vs. time during the recovery period).

For the experiments involving cremasteric arteriolar reactivity and alterations to arteriolar tone with progressive hemorrhage, the 20 LZR and 20 OZR were each divided into 4 groups of 5 animals. The first of these groups (i.e., 5 LZR and 5 OZR) had arteriolar reactivity to norepinephrine (10–10 to 10–7 M) and active tone determined under control (normovolemic) conditions. The second group had reactivity and active tone assessed after the first bleed only. Similarly, the third and fourth groups had these properties assessed only after the second and third blood withdrawals, respectively. In any individual experiment, after completion of the norepinephrine concentration-response curves, cremaster muscles were treated with 10–5 M phentolamine in the superfusate to determine adrenergic-dependent vs. -independent components of active tone. Muscles were subsequently treated with Ca2+-free PSS and adenosine to determine total active tone as described in Data and statistical analyses. This experimental procedure was necessary because neither treatment with phentolamine nor exposure to Ca2+-free PSS/adenosine were determined to be functionally reversible in the setting of increasing hemorrhage.

Data and statistical analyses.   All data are presented as means ± SE. After completion of a given experiment, the kidney, distal hindlimb, and small intestine, as appropriate, were removed, and the mass was determined for the normalization of all perfusion data. The ability of an animal to recover from progressive hemorrhage was estimated by determining the slope (using basic linear regression) of the MAP vs. time relationship over the 40 min after a given blood withdrawal. The ability of an animal to maintain tissue or organ perfusion after progressive hemorrhage was estimated by determining the percentage of the prewithdrawal perfusion that was present after 40 min of postwithdrawal recovery. Active tone for in situ arterioles was calculated as ({Delta}D/Dmax) x 100, where {Delta}D is the diameter increase from control in response to Ca2+-free PSS containing 10–3 M adenosine and Dmax is the maximum diameter measured under superfusion with Ca2+-free PSS containing 10–3 M adenosine. To determine the active tone that was independent of adrenergic influences, the identical equation was used, although in this case {Delta}D is the increase in arteriolar diameter after treatment of the cremaster with phentolamine (10–5 M) in response to Ca2+-free PSS containing 10–3 M adenosine. The adrenergic-dependent component of active tone was calculated as the difference between total active tone and adrenergic-independent active tone.

Statistically significant differences in basic characteristics, blood volume, and perfused tissue mass between LZR and OZR were determined using Student's t-test. Analysis of variance (ANOVA) was used to determine statistically significant differences in the effects of phentolamine on MAP and tissue perfusion, the slope of the MAP recovery curves following hemorrhage, posthemorrhage perfusion levels, and cremasteric arteriole active tone between LZR and OZR. Repeated-measures ANOVA was used to determine differences in arteriolar responses to norepinephrine between LZR and OZR. In all cases, Tukey's test was used post hoc, as appropriate, and P < 0.05 was taken to be statistically significant.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Baseline animal characteristics.   Data describing the baseline characteristics of LZR and OZR under the conditions of the present study are summarized in Table 1. By 15–17 wk of age, OZR were significantly heavier than their LZR counterparts and demonstrated a moderate elevation in blood pressure, as well as hyperglycemia, hyperinsulinemia, and severe hypertriglyceridemia. Total blood volume was not different between LZR and OZR, although when normalized for body mass, blood volume was reduced in OZR vs. lean animals. Some differences in organ mass were evident between LZR and OZR, as the single kidney mass and that of the small intestine was significantly elevated in obese animals. In contrast, distal hindlimb and gastrocnemius muscle mass was comparable between the two rat strains.


View this table:
[in this window]
[in a new window]
 
Table 1. Baseline characteristics of lean and obese Zucker rats used for the present study

 
Data describing MAP and blood flow through the renal, superior mesenteric, and distal femoral arteries, as well as perfusion within gastrocnemius muscle in LZR and OZR under control conditions and following pharmacological blockade of {alpha}1-/{alpha}2-adrenoreceptors with phentolamine are presented in Fig. 1. Infusion of phentolamine caused a reduction in MAP in both LZR and OZR, although the magnitude of this response was increased in obese animals (Fig. 1A; 19 ± 4% in LZR vs. 37 ± 5% in OZR; P < 0.05). Perfusion through the renal artery (Fig. 1B) was not different between LZR and OZR under control conditions, and infusion of phentolamine increased perfusion by a comparable amount in both strains. Splanchnic blood flow, as estimated by perfusion through the superior mesenteric artery, was elevated in OZR vs. LZR, despite correction for the hypertrophy of the intestinal tissue of the OZR (Fig. 1C). Adrenergic blockade, although having minimal impact on perfusion in OZR, significantly increased blood flow through the superior mesenteric artery in LZR. Under control conditions, blood flow within the distal femoral artery (Fig. 1D) and within the gastrocnemius muscle (Fig. 1E) was significantly reduced in OZR vs. LZR, and in both cases this difference between strains was reduced after infusion with phentolamine.


Figure 1
View larger version (46K):
[in this window]
[in a new window]
 
Fig. 1. Data describing hemodynamic alterations in adult male lean Zucker rats (LZR) and obese Zucker rats (OZR) (n = 5 animals for each strain) in response to intravenous infusion of the adrenoreceptor antagonist phentolamine (5 mg/kg). Data (means ± SE) are presented for mean arterial pressure (A), renal perfusion (B), splanchnic perfusion (C), distal hindlimb perfusion (D), and gastrocnemius muscle perfusion (E). *P < 0.05 vs. LZR control; {dagger}P < 0.05 vs. OZR control.

 
Figure 2 presents changes in MAP in LZR and OZR during the progressive hemorrhage protocol. Although higher before the first bleed, MAP fell more sharply in OZR than in LZR, such that no difference in pressure was determined after the first blood withdrawal. Although both groups experienced a recovery in MAP after the first bleed, the rate of recovery was slightly, although not significantly, greater in LZR vs. OZR (Table 2). After both the second and third bleeds, the rate of recovery in LZR significantly exceeded that in OZR. Finally, after the fourth blood withdrawal, LZR still demonstrated a partial recovery in MAP, although OZR entered into a decompensation phase.


Figure 2
View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2. Alterations in mean arterial pressure in LZR (n = 12) and OZR (n = 13) in response to incremental hemorrhage procedures (see text for details). Data (means ± SE) are presented as absolute changes in mean arterial pressure under control conditions and after 4 periods of blood withdrawal, each with 40 min of recovery time.

 

View this table:
[in this window]
[in a new window]
 
Table 2. Data describing the recovery of MAP and tissue/organ perfusion between LZR and OZR in response to 4 successive periods of incremental hemorrhage

 
Data describing alterations in tissue/organ perfusion during incremental hemorrhage in LZR and OZR are presented in Fig. 3. Although similar under control conditions, renal perfusion decreased to a greater extent in OZR vs. LZR after the first bleed and stabilized at a lower level (Fig. 3A). After a second bleed, renal perfusion fell further in OZR vs. LZR and demonstrated no significant recovery with time (Table 2). In response to each of the first two hemorrhage periods, splanchnic perfusion (Fig. 3B) fell to a greater extent in LZR vs. OZR, although the subsequent levels of perfusion were comparable between the two groups. After the third bleed, blood flow in the splanchnic perfusion fell more strongly in OZR than in LZR, and the very low perfusion was similar between the two groups. With regard to both distal hindlimb (Fig. 3C) and gastrocnemius muscle microvascular (Fig. 3D) perfusion, this process was reduced in OZR vs. LZR before blood withdrawal and fell more dramatically after the initial bleeds. Additionally, perfusion through both the femoral artery and gastrocnemius muscle microcirculation recovered less in OZR than in LZR after the first bleed (Table 2). This pattern was repeated after successive blood withdrawals, such that no significant recovery in gastrocnemius muscle perfusion after the second bleed was identified in OZR.


Figure 3
View larger version (33K):
[in this window]
[in a new window]
 
Fig. 3. Data describing the changes in perfusion of select tissues/organs under control conditions and after 4 successive periods of blood withdrawal, each followed by 40 min of recovery time (see text for details) in LZR (n = 5–7 animals) and OZR (n = 6–8 animals). Data (means ± SE) are presented as absolute changes in renal perfusion (A; ml·g–1·min–1), splanchnic perfusion (B; ml·g–1·min–1), distal hindlimb perfusion (C; ml·g–1·min–1), and gastrocnemius muscle capillary perfusion (D; LPU).

 
To further investigate the role of the adrenergic system in mediating the reductions in skeletal muscle perfusion with incremental hemorrhage, the data presented in Fig. 4 summarize the arteriolar reactivity for in situ cremaster muscle of LZR and OZR in response to increasing concentrations of norepinephrine. Figure 4A presents the constrictor responses of in situ arterioles after challenge with norepinephrine under control conditions. As evidenced in this panel, arterioles in OZR demonstrated an increased reactivity to the adrenergic agonist compared with responses of vessels from LZR. After the first bleed (Fig. 4B), arterioles from LZR exhibited a similar reactivity to norepinephrine as determined under control conditions, although vessels in OZR exhibited an increased tone before challenge with norepinephrine and an earlier incidence of closure with application of the agonist (Fig. 4C). This pattern was further exacerbated in response to the second bleed, where arteriolar diameter was considerably reduced in OZR vs. LZR, and most vessels closed completely in response to challenge with norepinephrine. Regardless of hemorrhage status, treatment of the cremaster muscle with 10–5 M phentolamine abolished constrictor reactivity to norepinephrine (data not shown).


Figure 4
View larger version (24K):
[in this window]
[in a new window]
 
Fig. 4. Initial diameter and constrictor reactivity of in situ cremasteric arterioles in response to increasing concentrations of norepinephrine in LZR and OZR (n = 5 animals for each strain under each condition) during control and after successive hemorrhage periods. Data (means ± SE) are presented under control conditions (A; normovolemia) and in response to periods of blood withdrawal [after first withdrawal (B), after second withdrawal (C) and after third withdrawal (D)]. *P < 0.05 vs. LZR.

 
Based on the data presented in Fig. 4, a calculation of active tone of in situ cremasteric arterioles of LZR and OZR can be made during the incremental hemorrhage (Fig. 5). Additionally, the contribution of adrenergic-dependent vs. -independent elements of arteriolar tone during these conditions in LZR and OZR can also be estimated after pharmacological blockade of {alpha}-adrenoreceptors with phentolamine. As shown in Fig. 5A, active tone of in situ cremasteric arterioles under control conditions was not different between LZR and OZR. However, after the initial bleed, arteriolar tone increased significantly in OZR, whereas this parameter was stable in LZR. After the second bleed, active tone increased in both rat strains, although this increase was more pronounced in OZR than in LZR. After treatment with phentolamine, where adrenergic influences are blocked, data presented in Fig. 5B suggest that adrenergic-independent elements contributing to active tone (e.g., myogenic activation) are not different for in situ cremasteric arterioles between LZR and OZR and that this relationship is not altered by progressive hemorrhage. In contrast, the percentage of active tone that is adrenergic dependent was significantly greater in arterioles of OZR vs. LZR and progressive hemorrhage increased this disparity between the two strains even further (Fig. 5C).


Figure 5
View larger version (16K):
[in this window]
[in a new window]
 
Fig. 5. Active tone levels calculated for in situ cremasteric arterioles of LZR and OZR (n = 5 animals for each strain under each condition) during control and after 3 periods of hemorrhage. Data (means ± SE) are presented as the total active tone of individual arterioles (A), the contribution of nonadrenergic-dependent elements to the total active tone (B), and the contribution of adrenergic-dependent elements to the total active tone (C). *P < 0.05 vs. LZR. {dagger}P < 0.05 vs. control.

 

    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Recent investigations in our laboratory (10, 21) and by others (20) have demonstrated an increased vasoconstrictor reactivity in response to adrenergic stimuli in both multiple organs and tissues of the obese Zucker rat. Given that additional studies have also suggested that activity within the adrenergic system can also be elevated with the development of obesity in both humans (5, 18, 24) and rodents (7, 17), the present study sought to determine whether these alterations could contribute to an improved ability of the obese Zucker rat to tolerate progressive hemorrhage, a physiological challenge to the cardiovascular system as a whole, the response to which is immediately dependent on sympathetic compensation (6).

The data presented in Fig. 1 suggest that the moderate hypertension that develops in OZR at this age (15–17 wk) may reflect an increased contribution through the sympathetic nervous system (Fig. 1A). Although, in some contrast to earlier investigation of hypertension within the OZR (2), this observation supports previous results from our laboratory and from others where intravenous infusion of {alpha}-adrenoreceptor antagonists (21) and ganglionic blockers (7) eliminated differences in MAP between LZR and OZR and partially alleviated differences in peripheral vascular resistance under resting conditions between the two strains (10, 11, 21). The additional panels in Fig. 1 suggest that this contribution of elevated adrenergic tone to increased MAP may reflect a preferential constriction of vessels in the skeletal muscle circulation and renal circulation, as blockade of adrenergic receptors with phentolamine significantly increased perfusion through these beds from control levels. In contrast, data presented in Fig. 1C suggest that adrenergic tone to the splanchnic circulation may be reduced in OZR vs. LZR, since blockade of {alpha}-adrenoreceptors had a minimal impact on perfusion in OZR, whereas blood flow was significantly elevated in LZR.

A recent study by Scheihofer et al. (20) provided evidence that blood volume, relative to body weight, is reduced in OZR compared with LZR. This observation was repeated in the present study, wherein blood volume (normalized to body mass) was reduced by nearly 40%. The obvious implication of this observation is that the volume withdrawal of blood during hemorrhage between OZR and LZR must be based on total blood volume, not on body mass (otherwise the severity of effects of each blood withdrawal will be biased against the obese animal). When corrected for this discrepancy, the results of the present study clearly suggest that the ability of OZR to tolerate hemorrhage is reduced compared with that determined in LZR (Fig. 2). OZR initially suffer a more severe fall in MAP after the first blood withdrawal (Fig. 2A) and consistently exhibited a reduced ability to restore normal blood pressure during the 40-min recovery period (Table 2). Additionally, OZR routinely demonstrated decompensation by the fourth blood withdrawal period, a condition that did not present itself in LZR.

The data presented in Fig. 3 provide some evidence describing how incremental hemorrhage impacts perfusion of specific tissues and organs within OZR. In this regard, the kidney (Fig. 3A), the hindlimb (Fig. 3C), and the skeletal muscle (Fig. 3D) all behave similarly in response to incremental blood loss. With systemic hemorrhage, perfusion to these regions of the body is reduced more rapidly in OZR than in LZR, ultimately resulting in a premature reduction in perfusion in these tissues of OZR vs. LZR. This premature reduction in perfusion may contribute to the impaired hemorrhage tolerance in OZR owing to a more rapid loss of the "buffer capacity" associated with hemorrhage tolerance. When incorporated with previous studies, this increased sensitivity in the reduction of perfusion with hemorrhage may be most closely associated with an increased vascular reactivity in response to adrenergic stimuli in these beds (10, 19, 21).

To further investigate the extent to which enhanced in situ skeletal muscle arteriolar constriction in response to a hemorrhagic stimuli could contribute to the premature reduction in perfusion, the reactivity of in situ cremasteric arterioles in response to norepinephrine (Fig. 4) and the adrenergic-dependent component of active tone (Fig. 5) were determined after each stage of incremental hemorrhage. While under control conditions, arterioles from OZR demonstrated an increased constrictor reactivity in response to norepinephrine and basal tone was not different between the two strains, suggesting that the cause of the reduced perfusion under resting conditions in skeletal muscle likely reflects an elevated vascular tone at larger resistance arterioles (10). As the severity of hemorrhage was increased, the tone of the distal arterioles of in situ cremsteric arterioles increased more rapidly in OZR than in LZR, resulting in a greater preponderance of vessels that achieved closure either before or after application of norepinephrine. Further analyses of these data and the respective contributions to the increased active tone suggested that this increased tone predominantly reflected an increase in the adrenergic-dependent elements of net vascular tone rather than the elements that are not dependent on adrenergic influences (Fig. 5).

In contrast to these data, adrenergic influences controlling vascular tone appear to be blunted in the splanchnic circulation of OZR vs. LZR, since perfusion of these tissues under control conditions was elevated in obese animals and the effect of adrenoreceptor blockade was attenuated. This observation is in general agreement with that from Schreihofer et al. (20) where phenylephrine-induced increases in vascular resistance were reduced in the splanchnic circulation of OZR vs. LZR. Interestingly, and in contrast to the other monitored tissues, incremental hemorrhage did not immediately result in a reduction in perfusion through the superior mesenteric artery of OZR. Rather, this response was less sensitive to blood withdrawal in OZR than in LZR for the initial bleed and only resulted in comparable reductions in perfusion after three hemorrhage periods. It remains to be determined whether the present results during hemorrhage reflect differences in the activity of the sympathetic nervous system within the splanchnic circulation of OZR relative to LZR, differences in the intrinsic reactivity of the splanchnic vasculature to adrenergic agonists, or a combination of both. Speculating a reduced sensitivity of the splanchnic circulation to hemorrhage-induced blood redistribution contributes to the premature reductions in perfusion with hemorrhage determined in the skeletal muscle, hindlimb, and renal circulations of OZR relative to LZR. It is conceivable that a more sensitive response in terms of the reduction in splanchnic perfusion following hemorrhage in OZR could minimize this premature reduction in renal and skeletal muscle perfusion and allow for a more normal hemorrhage tolerance. Further investigation into mechanisms of this disparity between the sensitivity of vascular beds to hemorrhage and adrenergic challenge in OZR and the implications for this in terms of whole body hemodynamics, blood pressure regulation, and hemostasis may be warranted.

The original hypothesis underlying this study was that the previously demonstrated enhanced adrenergic reactivity of the peripheral circulation, when combined with a normal or enhanced function of the sympathetic nervous system, would improve the ability of the adult OZR afflicted with the metabolic syndrome to withstand the physiological challenge to the cardiovascular system of progressive hemorrhage. Clearly, the results of the present study refute this original hypothesis. When taken together, it seems likely that, in the OZR, the combination of a reduced total blood volume (relative to body mass), an increased adrenergic constrictor reactivity in both the renal and skeletal muscle circulations, and a blunted adrenergic sensitivity in the splanchnic circulation impairs hemorrhage tolerance relative to that in LZR. The relative hypovolemia in OZR, when combined with an elevated adrenergic tone in the peripheral circulation of these animals, suggests that they may already exist in a state that is comparable to that of a mild hemorrhage. This condition, when combined with a loss of the buffer capacity to tolerate hemorrhage in terms of reducing peripheral perfusion and an imbalance in sympathetic responses between the splanchnic circulation and that of the renal and skeletal muscle circulations, results in a condition wherein the obese animal has lower reservoir of blood with which to perfuse vital organs and a compromised ability to adequately redirect perfusion to those vital organs during periods of hypovolemic stress.


    GRANTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant R01 DK-64668 and American Heart Association Grant 3303194N.


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
The authors thank Milinda R. James and Carmenza E. Mikell for expert technical assistance. The authors also thank Dr. Julian H. Lombard from the Medical College of Wisconsin for helpful suggestions and support during the performance of some of the experiments in the present study.


    FOOTNOTES
 

Address for reprint requests and other correspondence: J. C. Frisbee, Center for Interdisciplinary Research in Cardiovascular Science, Dept. of Physiology and Pharmacology, Robert C. Byrd Health Sciences Center, PO Box 9105, West Virginia Univ. School of Medicine, Morgantown, WV 26505 (e-mail: jfrisbee{at}hsc.wvu.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 

  1. Ajayi AA, Hercule H, Cory J, Hayes BE, and Oyekan AO. Gender difference in vascular and platelet reactivity to thromboxane A2-mimetic U46619 and to endothelial dependent vasodilation in Zucker fatty (hypertensive, hyperinsulinemic) diabetic rats. Diabetes Res Clin Pract 59: 11–24, 2003.
  2. Alonso-Galicia M, Brands MW, Zappe DH, and Hall JE. Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertension 28: 1047–1054, 1996.
  3. American Heart Association. American Heart Association Statistical Summary Sheet, "Metabolic Syndrome." Dallas, TX: American Heart Association, 2005. [http://www.americanheart.org/presenter.jhtml?identifier=3020708]
  4. American Heart Association. American Heart Association Statistical Summary Sheet, "Overweight, and Obesity." Dallas, TX: American Heart Association, 2005. [http://www.americanheart.org/presenter.jhtml?identifier=3000947]
  5. Astrup A and Macdonald IA. Sympathoadrenal system and metabolism. In: Handbook of Obesity, edited by Bray GA, Bouchard C, and James WPT. New York: Dekker, 1998, p. 491–511.
  6. Berne RM and Levy MN. Interplay of central and peripheral factors in the control of the circulation. In: Physiology, edited by Berne RM and Levy MN. St. Louis, MO: Mosby, 1998, p. 507–511.
  7. Carlson SH, Shelton J, White CR, and Wyss JM. Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats. Hypertension 35: 403–408, 2000.
  8. Center for Disease Control Information Pages. Overweight, and Obesity. Atlanta, GA: Center for Disease Control, 2005. [http://www.cdc.gov/nccdphp/dnpa/obesity/]
  9. Eckel RH, Grundy SM, and Zimmet PZ. The metabolic syndrome. Lancet 365: 1415–1428, 2005.
  10. Frisbee JC. Enhanced arteriolar alpha-adrenergic constriction impairs dilator responses and skeletal muscle perfusion in obese Zucker rats. J Appl Physiol 97: 764–772, 2004.
  11. Frisbee JC. Impaired skeletal muscle perfusion in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 285: R1124–R1134, 2003.
  12. Frisbee JC. Regulation of in situ skeletal muscle arteriolar tone: interactions between two parameters. Microcirculation 9: 443–462, 2002.
  13. Hall JE, Hildebrandt DA, and Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 14: 103–115, 2001.
  14. Hill MA, Simpson BE, and Meininger GA. Altered cremaster muscle hemodynamics due to disruption of the deferential feed vessels. Microvasc Res 39: 349–363, 1990.
  15. Macdonald IA. Advances in our understanding of the role of the sympathetic nervous system in obesity. Int J Obes Relat Metab Disord 19, Suppl 7: S2–S7, 1995.
  16. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, and Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289: 76–79, 2003.
  17. Morgan DA, Anderson EA, and Mark AL. Renal sympathetic nerve activity is increased in obese Zucker rats. Hypertension 25: 834–838, 1995.
  18. Poehlman ET, Gardner AW, Goran MI, Arciero PJ, Toth MJ, Ades PA, and Calles-Escandon J. Sympathetic nervous system activity, body fatness, and body fat distribution in younger and older males. J Appl Physiol 78: 802–806, 1995.
  19. Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, and Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 89: 2634–2640, 1994.
  20. Schreihofer AM, Hair CD, and Stepp DW. Reduced plasma volume and mesenteric vascular reactivity in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 288: R253–R261, 2005.
  21. Stepp DW and Frisbee JC. Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 282: H816–H820, 2002.
  22. Swenson SJ, Speth RC, and Porter JP. Effect of a perinatal high-salt diet on blood pressure control mechanisms in young Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 286: R764–R770, 2004.
  23. Turner NC, Gudgeon C, and Toseland N. Effects of genetic hyperinsulinaemia on vascular reactivity, blood pressure, and renal structure in the Zucker rat. J Cardiovasc Pharmacol 26: 714–720, 1995.
  24. Van Baak MA. The peripheral sympathetic nervous system in human obesity. Obesity Rev 2: 3–14, 2001.
  25. Vaz M, Jennings G, Turner A, Cox H, Lambert G, and Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 96: 3423–3429, 1997.
  26. Wang L. Plasma volume, cell volume, total blood volume and F cells factor in normal and splenectomized Sherman rat. Am J Physiol 196: 188–192, 1959.
  27. Wayneforth HB and Flecknell PA. Experimental and Surgical Technique in the Rat (2nd ed.). London, UK: Academic, 2001, p. 341–358.



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. A. Phillips
Effects of low-carbohydrate diet on vascular health: more than just weight loss
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2037 - H2039.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. C. Frisbee
Vascular adrenergic tone and structural narrowing constrain reactive hyperemia in skeletal muscle of obese Zucker rats
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2066 - H2074.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
100/2/465    most recent
01062.2005v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frisbee, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frisbee, J. C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.